You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
大博醫療(002901.SZ):9371萬元收購椎間孔鏡設備和配套器械耗材企業安德思考普51%股權
格隆匯 05-14 19:08

格隆匯5月14日丨大博醫療(002901.SZ)公佈,公司於2021514日召開第二屆董事會第十五次會議審議通過了《關於收購北京安德思考普商貿有限公司51%股權的議案》,為進一步加快公司在脊柱產品線的全面佈局,結合臨牀脊柱手術微創化的趨勢,同意公司以自有資金出資9371萬人民幣收購椎間孔鏡設備和配套器械耗材企業北京安德思考普商貿有限公司(“安德思考普”或“目標公司”)51%的股權。此次收購完成後,安德思考普成為公司控股子公司。

結合臨牀脊柱手術微創化的趨勢,此次併購對於公司在脊柱領域的全面佈局至關重要。目標公司的產品包括椎間孔鏡設備和配套的器械耗材,這與公司現有的骨科產品線互相補充,相輔相成。同時,大博醫療現有的研發團隊和目標公司的研發團隊可以充分整合,針對脊柱微創手術研發更多符合臨牀需求的創新型產品,增強大博醫療脊柱產品線的綜合競爭力。

在產線的整合互補之外,在市場運營方面,大博醫療和目標公司的現有的渠道資源可以互相結合,互相加強。目標公司的核心產品與大博醫療的脊柱產品線均主要應用於脊柱外科臨牀,因此在終端客户上,兩者具有共享性。大博醫療脊柱產品的銷售渠道可以與目標公司的椎間孔鏡相關產品實現一定的渠道共享和資源互補,這將在一定程度上優化整體市場資源配置,提高學術推廣的效率。

此次併購後,公司將以原有脊柱產品線為基礎,擴充微創脊柱產品線,提升脊柱產品線的整體競爭力。脊柱產品作為骨科的三大產線之一,在公司整體的戰略佈局中非常重要,此次併購也是公司骨科戰略中關鍵的一環,通過與目標公司的資源整合,將提升公司脊柱產品的技術壁壘,增強公司產品在集採、兩票制等政策中競爭力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account